Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.91% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-03-26
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-03-31 was 4.33%.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 3.91%, a 9.70% decline from fiscal 2024.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.33%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 3.91% 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 3.91% 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 3.91% 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | 4.33% 10-K · filed 2026-03-26 | |||
| 2024-09-30 | 4.33% 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 4.33% 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | 4.33% 10-Q · filed 2025-05-14 |